We failed to meet primary clinical endpoint in our Ph3 trial for Crohns. Why is this not surprising? This truly is the gang that couldn't shoot straight. Clear the deck of all of these "paper leaders" and get some people in here who know WTF they are doing!!!! Countless other companies could get paper bags approved for Asthma and we can design a trial to meet an endpoint?!!! Patient cohorts and data analytics... it aint that difficult!!! Perhaps now the board will start thinking about all the failures we have running this place and do what Bayer just did and wipe them all clean into the dustbin of failed McKinsey/HBR leadership wannabees
